Abstract

PurposeTo determine the correlation between the parameters of MR diffusion kurtosis imaging (MR-DKI) and mismatch repair gene expression (MMR) for rectal carcinomas.Materials and methodsData from 80 patients with rectal carcinoma were analyzed in this prospective study. High-resolution T2WI and DKI (b = 0, 800 and 1600 s/mm2, respectively) were performed. Mean kurtosis (MK) and mean diffusivity (MD) from DKI were measured. MMR-positive expression and HER-2 expression were classified into two groups. For comparison between different grades, the Mann-Whitney U test, receiver operating characteristic curve, and Spearman’s correlation analysis were used for statistical analyses.ResultsThe MK values in identifying positive MMR expressions (MLH1, MSH2, and MSH6) were more reliable than the MD values (rs value: 0.772 vs. 0.448, 0.733 vs. 0.499, and 0.828 vs. 0.633 respectively, P<0.01). Receiver operating curve analysis showed that the performances of the MK values were better than those of the MD values (z = 2.835, 2.000, and 2.827, respectively, P<0.05), while the performances of the MK and MD-MK values were not statistically significant (z = 0.808, 1.557, and 0.596, respectively, P>0.05). Similarly, MK values were better than MD values in identifying HER2 expression (z = 2.795, P<0.05).ConclusionsMK derived from DKI demonstrated a greater correlation than MD with MMR expression. It also showed better performance in differentiating between high- and low-grade positive MMR expression and HER2 expression. Thus, DKI may be valuable for the prognoses and evaluation of non-invasive therapies.

Highlights

  • Rectal carcinoma is one of the most common malignant tumors [1,2], with an increasing occurrence

  • Receiver operating curve analysis showed that the performances of the Mean kurtosis (MK) values were better than those of the mean diffusivity (MD) values (z = 2.835, 2.000, and 2.827, respectively, P0.05)

  • MK derived from Diffusion kurtosis imaging (DKI) demonstrated a greater correlation than MD with mismatch repair gene expression (MMR) expression

Read more

Summary

Introduction

Rectal carcinoma is one of the most common malignant tumors [1,2], with an increasing occurrence. The treatment of rectal carcinoma includes surgery and neoadjuvant chemoradiotherapy (CRT). For locally advanced rectal cancer (LARC), CRT is the most commonly treatment, which may reduce the ratio of local recurrence [3] and improve the results of resection. Detection and assessment of treatment response before the onset of CRT would be helpful to identify appropriate patients to avoid ineffective and potentially toxic therapy [5]. MMR proteins, including MLH1, MSH2, MSH6, and HER2, can only be evaluated by mass biopsy. Biopsy is invasive and may cause complications.

Objectives
Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.